Viewing data from:

AMITRIPTYLINE HYDROCHLORIDE

ANDA

AMITRIPTYLINE HYDROCHLORIDE | A212654 | AIPING PHARMACEUTICAL INC

6 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 18 NDCs

Highest NADAC/Unit

$0.2973

per ea

Lowest NADAC/Unit

$0.0294

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
69367039301AMITRIPTYLINE HCL 150 MG TAB	$0.2973	EA	Generic	—	2026-06-17
11788008201AMITRIPTYLINE HCL 150 MG TAB	$0.2973	EA	Generic	—	2026-06-17
69367039201AMITRIPTYLINE HCL 100 MG TAB	$0.1506	EA	Generic	—	2026-06-17
11788008101AMITRIPTYLINE HCL 100 MG TAB	$0.1506	EA	Generic	—	2026-06-17
69367039101AMITRIPTYLINE HCL 75 MG TAB	$0.1112	EA	Generic	—	2026-06-17
11788008001AMITRIPTYLINE HCL 75 MG TAB	$0.1112	EA	Generic	—	2026-06-17

Showing 6 of 18 NDCs.

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain5 active DMFs4 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

DIPHARMA FRANCIS SRLAMITRIPTYLINE HYDROCHLORIDE

DMF 29081977

RL FINE CHEM PVT LTDAMITRIPTYLINE HYDROCHLORIDE

DMF 181112005

SUN PHARMACEUTICAL INDUSTRIES LTDAMITRIPTYLINE HYDROCHLORIDE USP

DMF 195892006

VASUDHA PHARMA CHEM LTDAMITRIPTYLINE HYDROCHLORIDE USP

DMF 196352006

MANKIND PHARMA LTDAMITRIPTYLINE HYDROCHLORIDE USP

DMF 335652019

KV PHARMACEUTICAL COInactiveAMITRIPTYLINE HYDROCHLORIDE

DMF 24131975

EGIS PHARMACEUTICALS PRIVATE LTDInactiveAMITRIPTYLINE HYDROCHLORIDE

DMF 70591987

MERIND LTDInactiveAMITRIPTYLINE HYDROCHLORIDE USP

DMF 110271994

WANBURY LTDInactiveAMITRIPTYLINE

DMF 181742005

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (6)

Sort:

#001 — 25MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Apr 7, 2020

No patent or exclusivity listings for this strength.

#002 — 10MG

0 patents0 exclusivities▾